A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2006
12/12/2006	US7148214 Antihistaminic spiro compounds
12/12/2006	US7148212 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension.
12/12/2006	US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/12/2006	US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148200 Adenocarcinogenic agent
12/12/2006	US7148012 Therapeutic agent for fibromyalgia
12/12/2006	US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006	US7147877 Method for treating lesions caused by estrogen deficiency with extract of cucumber
12/12/2006	US7147847 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2347741C Thiazole-derivatives
12/12/2006	CA2286076C Use of 5ht3 antagonists for promoting intestinal lavage
12/12/2006	CA2257931C Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/12/2006	CA2245926C 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
12/12/2006	CA2215680C Prilocaine and hydrofluorocarbon aerosol preparations
12/12/2006	CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine
12/12/2006	CA2159355C Method and composition for treatment of osteoporosis
12/12/2006	CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006	WO2006130034A1 Method for increasing longevity of a human being and animals
12/07/2006	WO2006129881A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent
12/07/2006	WO2006129877A1 Novel anti-inflammatory agent
12/07/2006	WO2006129876A1 Body odor improving agent for ingestion into body, beverage/food using the same, and method for improvement body odor
12/07/2006	WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006129803A1 Novel temporal gene and application of the same
12/07/2006	WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129743A1 Skin whitening agent, melanin formation inhibitor, and cosmetic, pharmaceutical and beverage composition comprising the agent or inhibitor
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006129609A1 2-naphthylimino-5,5-disubstituted-1,3-thiazin derivative
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129479A1 Gastrointestinal drug composition
12/07/2006	WO2006129393A1 Composition for treating periodontal disease
12/07/2006	WO2006128337A1 A pharmaceutical composition for prevention and treatment of menopausal syndrome and method of preparing the same
12/07/2006	WO2006099256A3 Modulators of atp-binding cassette transporters
12/07/2006	WO2006037335A3 Use of compounds for the prevention of drug-induced cell toxicity
12/07/2006	WO2004024882A3 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/07/2006	US20060277614 Mammal prolactin variants
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276517 Non-systemic control of parasites
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276491 Therapeutic compounds
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276452 Use of azetidinecarboxamide derivatives in therapy
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/07/2006	US20060276415 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
12/07/2006	US20060276399 Peptide antagonists of zonulin and methods for use of the same
12/07/2006	US20060276397 Crystallization of IGF-1
12/07/2006	US20060276381 Remedy for diabetes
12/07/2006	US20060275898 Compositions and Methods for Making Embryonic Stem Cells
12/07/2006	US20060275868 Fusion proteins comprising tumor necrosis factor receptor
12/07/2006	US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/07/2006	US20060275359 Palliative effects of morinda citrifolia oil and juice
12/07/2006	US20060275328 Instrument for inducing cytokine and method of inducing cytokine
12/07/2006	US20060275305 HERCEPTIN adjuvant therapy
12/07/2006	US20060275301 Cell death-inducing agent
12/07/2006	US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
12/07/2006	US20060275289 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
12/07/2006	US20060275287 Scroll compressor
12/07/2006	US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006	US20060275268 Compositions for activating the infiltration activity of dendritic cells, and immunopotentiating agents
12/07/2006	US20060275258 Interferon-alpha induced gene
12/07/2006	CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
12/07/2006	CA2609388A1 Novel piperidine derivative
12/06/2006	EP1728802A2 ErbB3 antibodies
12/06/2006	EP1728515A1 Influenza virus-infection inhibitor
12/06/2006	EP1728510A2 Treating cancer by increasing intracellular malonyl coA levels
12/06/2006	EP1728504A1 Emulsion stabilizer
12/06/2006	EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/06/2006	EP1727552A1 Tissue repair with multipotent cells
12/06/2006	EP1727546A2 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
12/06/2006	EP1727538A2 Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
12/06/2006	EP1727536A1 Beta-lapachone and s-phase drug combinations for cancer treatment
12/06/2006	EP1682571A4 A bidentate motif and methods of use
12/06/2006	EP1682570A4 A binding motif and methods of regulating cell function
12/06/2006	EP1505066B1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
12/06/2006	EP1438304B1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/06/2006	EP1397135B1 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways
12/06/2006	EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/06/2006	EP1345610B1 Quetiapine for treating of dyskinesia in non-psychotic patients
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/06/2006	EP1218381B1 AMINO SUBSTITUTED PYRAZOLO¬1,5-a\|-1,5-PYRIMIDINES AND PYRAZOLO¬1,5-a\|-1,3,5-TRIAZINES
12/06/2006	EP1165078B1 Methods of inducing cancer cell death and tumor regression
12/06/2006	EP1091738B1 BICYCLIC sPLA 2 INHIBITORS
12/06/2006	EP1069893B1 Use of dexmedetomidine for icu sedation
12/06/2006	EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases
12/06/2006	EP0837934B1 Human vascular endothelial growth factor 2
12/06/2006	EP0740701B1 Mammalian monocyte chemoattractant protein receptors
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006	CN1872879A Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage
12/06/2006	CN1872850A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative

1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 1564